Mode
Text Size
Log in / Sign up

ST-Elevation Myocardial Infarction

Part of Myocardial ischemia

12 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for ST-Elevation Myocardial Infarction

6 trials tracked for ST-Elevation Myocardial Infarction: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 12 citations.

6Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 2 Other / NA 3
  1. Phase 3 Ticagrelor Administered as Standard Tablet or Orodispersible Formulation Completed · 12 cited
  2. Phase 2 Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction Completed
  3. Phase 2 A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction Completed
  4. N/A Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion Completed
  5. N/A CArdiac Brief INtervention: A Feasibility Study to Promote Engagement With Cardiac Rehabilitation Completed
  6. N/A Early Discharge After Primary Percutaneous Coronary Intervention Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

ST-Elevation Myocardial Infarction: what the trials found

In the management of ST-elevation myocardial infarction, ticagrelor orodispersible tablets were evaluated for antiplatelet efficacy. Data indicated that 51% and 53% of patients experienced insufficient antiaggregation 3.

Regarding residual platelet reactivity over various timepoints, 42 and 9 participants were identified as having such reactivity 3.

Recent results — preliminary, needs further review

  • Methylprednisolone was evaluated in a Phase 2 study (N=530) 1.
  • The Cardiac Brief Intervention (CABIN) was assessed; while 100% of the intended dose was delivered, only 17% and 18% of recruited participants provided data for all baseline and outcome measures 2.

For the clinician treating this condition

  • Ticagrelor orodispersible tablets are associated with specific rates of insufficient antiaggregation (51% and 53%) in patients with ST-elevation myocardial infarction 3.
  • Residual platelet reactivity following ticagrelor administration was observed in 42 and 9 participants at various timepoints 3.

AI synthesis of 3 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Myocardial ischemia

Related studies from across the Myocardial ischemia family.

Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI Patients
Cardiology RCT
Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI Patients Physiology guided heart procedures show lower risk of major events
Physiology-guided revascularization significantly reduces major adverse cardiac events and improves safety profiles compared to traditional …
A large international trial shows that using functional imaging to guide heart artery procedures may lower the risk of stroke and heart atta…
High-intensity statin adherence correlates with greater LDL-C reductions and improved plaque stability post-AMI
Cardiology RCT
High-intensity statin adherence correlates with greater LDL-C reductions and improved plaque stability post-AMI High-Intensity Statins Show Better Results for Heart Patients Following Heart Attack
This randomized controlled trial sub-study of 255 patients with acute myocardial infarction evaluated high-intensity statin therapy. Adheren…
Patients who strictly followed their high-intensity statin regimen after a heart attack showed significantly better improvements in heart he…
GLP-1 receptor agonists reduce MACE (HR 0.69) and all-cause mortality (HR 0.67) in Type 2 Diabetes
Cardiology Meta-analysis
GLP-1 receptor agonists reduce MACE (HR 0.69) and all-cause mortality (HR 0.67) in Type 2 Diabetes GLP-1 medications show promise for heart health in diabetes
This meta-analysis of 37,393 patients with Type 2 Diabetes and myocardial infarction-defined populations found that GLP-1 receptor agonists …
A large review of over 37,000 patients suggests GLP-1 medications may lower heart failure risks for those with Type 2 Diabetes.
Ticagrelor monotherapy following primary PCI for STEMI shows reduced non-access site bleeding
Cardiology RCT
Ticagrelor monotherapy following primary PCI for STEMI shows reduced non-access site bleeding Trial shows ticagrelor monotherapy may reduce bleeding after heart attack
This pilot study compared ticagrelor monotherapy against ticagrelor plus aspirin in patients with STEMI after primary PCI. The trial reporte…
A pilot study suggests that using ticagrelor alone after a heart attack may reduce specific types of bleeding compared to a dual-drug approa…
High-dose statin preloading increases TIMI flow grade 3 and reduces all-cause mortality in STEMI
Cardiology Meta-analysis
High-dose statin preloading increases TIMI flow grade 3 and reduces all-cause mortality in STEMI High dose statins may improve outcomes for heart attack patients
This meta-analysis of 1862 patients with STEMI undergoing primary PCI indicates that high-dose statin preloading is associated with improved…
A high dose of statins before a heart procedure may improve blood flow and lower death rates for patients with a heart attack.
Moderate-intensity aerobic exercise improves cardiopulmonary function and pathological remodeling in myocardial infarction patients
Cardiology Sys. Review
Moderate-intensity aerobic exercise improves cardiopulmonary function and pathological remodeling in myocardial infarction patients Different types of exercise help heart health after a heart attack
This network meta-analysis of 3170 patients with myocardial infarction (MI) evaluated various exercise modalities for improving cardiopulmon…
New data shows that different types of exercise, from aerobic training to mind-body movements, can improve heart function after a heart atta…
Pressure optimization protocol improves reperfusion success and reduces postdilation in STEMI patients
Cardiology RCT
Pressure optimization protocol improves reperfusion success and reduces postdilation in STEMI patients New stenting technique improves blood flow after heart attacks
This multicenter randomized trial of 607 patients undergoing primary PCI for STEMI found that a pressure optimization protocol (POP) signifi…
A new pressure optimization method during heart surgery helps restore blood flow faster and reduces the need for extra procedures.
R.E.N.A.L., PADUA, and (MC)2 scoring systems correlate with increased complication risks in renal tumor ablation
Oncology Meta-analysis
R.E.N.A.L., PADUA, and (MC)2 scoring systems correlate with increased complication risks in renal tumor ablation Scoring systems help predict complications after renal tumor ablation
This meta-analysis of 25 retrospective studies evaluates the R.E.N.A.L., PADUA, and (MC)2 scoring systems for predicting complications follo…
New analysis shows that specific scoring systems can help doctors predict and manage risks for patients undergoing surgery to remove kidney …
Eight traditional Chinese medicine injections combined with conventional medicine improve outcomes in post-AMI heart failure
Cardiology Meta-analysis
Eight traditional Chinese medicine injections combined with conventional medicine improve outcomes in post-AMI heart failure Comparing Different Traditional Chinese Medicine Injections for Heart Failure Recovery
This systematic review and network meta-analysis of 62 RCTs involving 5922 participants evaluated eight traditional Chinese medicine injecti…
New research looks at how different herbal injections can help patients recover from heart attacks when used with standard medicine.
Traditional Chinese medicine integrated with cardiac rehabilitation addresses inflammation, autonomic dysfunction, and psychological disorders
Cardiology Sys. Review
Traditional Chinese medicine integrated with cardiac rehabilitation addresses inflammation, autonomic dysfunction, and psychological disorders Traditional Chinese medicine may help patients recover from heart attacks
This narrative review examines the integration of Traditional Chinese medicine (TCM) into cardiac rehabilitation for patients with cardiovas…
Integrating Traditional Chinese medicine with standard cardiac rehab could help manage inflammation and stress after heart surgery or a hear…
Dual antiplatelet therapy reduces all-cause death but not MACE or myocardial infarction in MINOCA
Cardiology Meta-analysis
Dual antiplatelet therapy reduces all-cause death but not MACE or myocardial infarction in MINOCA Dual antiplatelet therapy shows survival benefits for MINOCA patients
This meta-analysis of 13027 patients with myocardial infarction with nonobstructive coronary artery disease (MINOCA) found that dual antipla…
New data suggests that dual antiplatelet therapy may help reduce the risk of death in patients with a specific type of heart attack.
Adjunctive intracoronary thrombolysis reduces major adverse cardiovascular events in patients with STEMI
Cardiology Meta-analysis
Adjunctive intracoronary thrombolysis reduces major adverse cardiovascular events in patients with STEMI Intracoronary Thrombolysis Linked to Lower Risks After Heart Attack
This meta-analysis evaluated the impact of adjunctive intracoronary thrombolysis during primary percutaneous coronary intervention for patie…
Adding intracoronary thrombolysis during heart procedures may lower the risk of major complications and improve blood flow for patients with…

Questions about ST-Elevation Myocardial Infarction

Does having a family history of sudden death make ventricular fibrillation more likely in STEMI?

Yes, a family history of sudden death independently raises the odds of ventricular fibrillation during a first STEMI by about 60%, according to a large meta-analysis.

Full answer →